Yann Gibert, PhD
My laboratory uses the vertebrate model zebrafish to model human diseases and disorders. Using genome editing techniques (CRISPR/cas) and transgenic technologies my laboratory aims to study metabolic genetic diseases, such as diabetes, obesity but also cancer.
My laboratory developed new techniques to study metabolism in vivo such as measuring metabolic respiration using the Seahorse Bio-analyzer and performing full lipidomics assay during vertebrate embryonic development using the zebrafish as model.
Throughout the years, the following organizations have supported my work: Association de Recherche contre le Cancer (ARC, France); National Health and Medical Research Council (NHMRC, Australia), Diabetes Australia Research Trust (DART, Australia).